I have always enjoyed working with children, and I like the combination of clinical care and surgery that ophthalmology provides. I treat nearly all aspects of pediatric ophthalmology, and I’m particularly interested in intraocular surgery, including pediatric cataracts and glaucoma.
As a pediatric ophthalmologist, I treat children and adolescents with:
I treat every patient and family with respect and care while I provide comprehensive pediatric ophthalmology services in an efficient manner.
In my research, I’m involved with the Pediatric Eye Disease Investigator Group (PEDIG). We study many aspects within pediatric ophthalmology, particularly amblyopia and strabismus.
I enjoy spending my free time playing the piano, watching movies and playing softball.
BA: Cornell University, Ithaca, NY, 2002.
MD: University of Cincinnati, Cincinnati OH, 2007.
Internship: Internal Medicine (PGY1), The Jewish Hospital, Cincinnati OH, 2007-2008.
Residency: Ophthalmology (PGY2-4), University of Cincinnati, Cincinnati OH, 2008-2011.
Fellowship: Pediatric Ophthalmology (PGY5), Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2011-2012.
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes. Ophthalmology: Journal of The American Academy of Ophthalmology. 2022; 129:1120-1128.
Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants. JAMA Ophthalmology. 2022; 140:337-344.
Visual Outcomes and Complications After Lensectomy for Traumatic Cataract in Children. JAMA Ophthalmology. 2021; 139:647-653.
The flipped-classroom approach to teaching horizontal strabismus in ophthalmology residency: a multicentered randomized controlled study. Journal of American Association for Pediatric Ophthalmology and Strabismus. 2021; 25:137.e1-137.e6.
Overminus Lens Therapy for Children 3 to 10 Years of Age With Intermittent Exotropia: A Randomized Clinical Trial. JAMA Ophthalmology. 2021; 139:464-476.
Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity. JAMA Ophthalmology. 2020; 138:14-20.